Humana plans major changes to its Medicare Advantage plans in 2027, focusing on profitability over growth, which could affect ...

Humana’s CenterWell Pharmacy business and Mark Cuban’s Cost Plus Drugs have tied the knot on a partnership focused on ...

Humana stock in focus after earnings and guidance shift Humana (HUM) is back on investors’ radar after first quarter results, ...

Humana affirmed its outlook for 2026 on Wednesday morning, though the company's shares fell premarket as future star ratings ...

Insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the ...

Margin improvement and MA member retention are doable, as are top-quartile star-rating results in 2028, company says.

Humana reported first quarter net income of nearly $1.2 billion as costs of care for older adults in its Medicare Advantage ...

Humana (HUM) stock slides despite a Q1 beat as the company reaffirmed its 2026 EPS guidance due to Medicare Star Ratings cuts. Read more here.

Humana Inc.’s first-quarter profit exceeded Wall Street’s estimates though the company maintained its full-year guidance, suggesting it may foresee difficulties later in the year.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The April scoreboard is in for managed care. UnitedHealth Group (NYSE:UNH) stock and Humana (NYSE:HUM) stock both staged ...